|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-5-9
|
|
pubmed:abstractText |
To assess the long-term survival results after cisplatin, protracted infusion 5-fluorouracil, and concurrent radiotherapy (RT) followed by surgical resection of esophageal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
328-34
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12738305-Adenocarcinoma,
pubmed-meshheading:12738305-Adult,
pubmed-meshheading:12738305-Aged,
pubmed-meshheading:12738305-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12738305-Carcinoma, Squamous Cell,
pubmed-meshheading:12738305-Cisplatin,
pubmed-meshheading:12738305-Combined Modality Therapy,
pubmed-meshheading:12738305-Esophageal Neoplasms,
pubmed-meshheading:12738305-Esophagectomy,
pubmed-meshheading:12738305-Female,
pubmed-meshheading:12738305-Fluorouracil,
pubmed-meshheading:12738305-Humans,
pubmed-meshheading:12738305-Male,
pubmed-meshheading:12738305-Middle Aged,
pubmed-meshheading:12738305-Proportional Hazards Models,
pubmed-meshheading:12738305-Survival Rate
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
|
|
pubmed:affiliation |
Sidney Kimmel Oncology Center at Johns Hopkins, Baltimore, MD 21231, USA. Kleinla@jhmi.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
